Cover Image
市場調查報告書

全身性乾癬治療藥的全球市場:2018年∼2022年

Global Systemic Psoriasis Therapeutics Market 2018-2022

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 363474
出版日期 內容資訊 英文 126 Pages
訂單完成後即時交付
價格
Back to Top
全身性乾癬治療藥的全球市場:2018年∼2022年 Global Systemic Psoriasis Therapeutics Market 2018-2022
出版日期: 2018年08月16日 內容資訊: 英文 126 Pages
簡介

關於全身性乾癬治療藥

乾癬,是全球人口約有2%受侵犯的慢性皮膚疾病。其形態有平常性、逆行性、膿皰性及水滴狀等的乾癬。

Technavio的分析師預測,從2018年到2022年之間,全身性乾癬治療藥市場將以10.07%的年複合成長率成長。

本報告提供全球全身性乾癬治療藥市場相關調查分析,市場規模與成長率,市場趨勢,市場的推動要素與課題,市場機會驗證,主要供應商等相關的系統性資訊。

目錄

第1章 摘要整理

第2章 調查範圍

第3章 調查方法

第4章 市場情形

  • 市場生態系統
  • 市場特性
  • 市場區隔分析

第5章 市場規模

  • 市場定義
  • 市場規模(2017年)
  • 市場規模及預測(2017-2022年)

第6章 波特的五力分析

  • 買主談判力
  • 供應商談判力
  • 新加入廠商的威脅
  • 替代品的威脅
  • 競爭對手的威脅
  • 市場情形

第7章 開發平台分析

  • 開發平台分析
  • 中止的乾癬治療

第8章 市場區隔:各產品

  • 市場區隔:各產品(2017-2022年)
  • 比較:各產品
  • 小分子
  • 生技藥品
  • 市場機會:各產品

第9章 市場區隔:各投藥途徑

  • 市場區隔:各投藥途徑
  • 口服
  • 非口服

第10章 市場區隔:疾病的各重症度

  • 市場區隔:疾病的各重症度

第11章 市場區隔:各終端用戶

  • 市場區隔:各終端用戶
  • 醫院
  • 零售藥局

第12章 客戶形勢

第13章 地區形勢

  • 各地區市場區隔(2017-2022年)
  • 地區比較
  • 南北美洲
  • 歐洲、中東、非洲地區
  • 亞太地區
  • 市場機會

第14章 決策架構

第15章 成長要素與課題

  • 市場成長要素
  • 市場課題

第16章 市場趨勢

  • 全身性乾癬治療的成本的上升
  • 生技藥品的引進
  • 乾癬的基因治療
  • 聯合治療的使用
  • 精密醫療保健基礎設施的研究

第17章 業者情勢

  • 概要
  • 創造性破壞狀況

第18章 供應商分析

  • 交易廠商
  • 供應商分類
  • 供應商的市場定位
  • AbbVie
  • Amgen
  • Celgene
  • Johnson & Johnson

第19章 附錄

  • 簡稱的清單

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: IRTNTR23218

About Systemic Psoriasis Therapeutics

Psoriasis is a chronic skin disease affecting about 2% of the world's population. Different forms of psoriasis include plaque, inverse, pustular, and guttate psoriasis.

Technavio's analysts forecast the Global Systemic Psoriasis Therapeutics Market to grow at a CAGR of 10.07% during the period 2018-2022.

Covered in this report

The report covers the present scenario and the growth prospects of the systemic psoriasis therapeutics market. To calculate the market size, the report considers the revenue generated from sale of different systemic psoriasis therapeutics.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Systemic Psoriasis Therapeutics Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • AbbVie
  • Amgen
  • Celgene
  • Johnson & Johnson

Market driver

  • Need for affordable therapies
  • For a full, detailed list, view our report

Market challenge

  • Patent expiry of drugs
  • For a full, detailed list, view our report

Market trend

  • Rise in cost of systemic psoriasis therapy
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 05: MARKET SIZING

  • Market definition
  • Market sizing 2017
  • Market size and forecast 2017-2022

PART 06: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 07: PIPELINE ANALYSIS

  • Pipeline analysis
  • Discontinued psoriasis therapies

PART 08: MARKET SEGMENTATION BY PRODUCT

  • Segmentation by product
  • Comparison by product
  • Small molecules - Market size and forecast 2017-2022
  • Biologics - Market size and forecast 2017-2022
  • Market opportunity by product

PART 09: MARKET SEGMENTATION BY ROA

  • Segmentation by ROA
  • Oral
  • Parenteral

PART 10: MARKET SEGMENTATION BY SEVERITY OF DISEASE

  • Segmentation by severity of disease

PART 11: MARKET SEGMENTATION BY END-USER

  • Segmentation by end-user
  • Hospitals
  • Retail pharmacies

PART 12: CUSTOMER LANDSCAPE

PART 13: REGIONAL LANDSCAPE

  • Geographical segmentation
  • Regional comparison
  • Americas - Market size and forecast 2017-2022
  • EMEA - Market size and forecast 2017-2022
  • APAC - Market size and forecast 2017-2022
  • Market opportunity

PART 14: DECISION FRAMEWORK

PART 15: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 16: MARKET TRENDS

  • Rise in cost of systemic psoriasis therapy
  • Introduction of biologics
  • Gene therapy for psoriasis
  • Use of combination therapy
  • Research in precision healthcare infrastructure

PART 17: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 18: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • AbbVie
  • Amgen
  • Celgene
  • Johnson & Johnson

PART 19: APPENDIX

  • List of abbreviations

List of Exhibits

  • Exhibit 01: Parent market
  • Exhibit 02: Global dermatological drugs market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Market definition - Inclusions and exclusions checklist
  • Exhibit 06: Market size 2017
  • Exhibit 07: Validation techniques employed for market sizing 2017
  • Exhibit 08: Global systemic psoriasis therapeutics market - Market size and forecast 2017-2022 ($ bn)
  • Exhibit 09: Global systemic psoriasis therapeutics market - Year-over-year growth 2018-2022 (%)
  • Exhibit 10: Five forces analysis 2017
  • Exhibit 11: Five forces analysis 2022
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of rivalry
  • Exhibit 16: Market condition - Five forces 2017
  • Exhibit 17: Relationship between need, supply, and demand
  • Exhibit 18: List of biosimilars approved by FDA for psoriasis
  • Exhibit 19: List of biosimilars approved by European Medicines Agency (EMA) for psoriasis
  • Exhibit 20: List of biologics and small molecules (phase II and III in pipeline) and MOA
  • Exhibit 21: List of biosimilars (phase II and III in pipeline) and MOA
  • Exhibit 22: Biologics targeting IL-23 and IL-17
  • Exhibit 23: Global systemic psoriasis therapeutics market by product - Market share 2017-2022 (%)
  • Exhibit 24: Comparison by product
  • Exhibit 25: Global systemic psoriasis therapeutics market by small molecules - Market size and forecast 2017-2022 ($ bn)
  • Exhibit 26: Global systemic psoriasis therapeutics market by small molecules - Year-over-year growth 2018-2022 (%)
  • Exhibit 27: Global systemic psoriasis therapeutics market by biologics - Market size and forecast 2017-2022 ($ bn)
  • Exhibit 28: Global systemic psoriasis therapeutics market by biologics - Year-over-year growth 2018-2022 (%)
  • Exhibit 29: Market opportunity by product
  • Exhibit 30: Customer landscape
  • Exhibit 31: Global systemic psoriasis therapeutics market by region - Market share 2017-2022 (%)
  • Exhibit 32: Regional comparison
  • Exhibit 33: Global systemic psoriasis therapeutics market in Americas - Market size and forecast 2017-2022 ($ bn)
  • Exhibit 34: Global systemic psoriasis therapeutics market in Americas - Year-over-year growth 2018-2022 (%)
  • Exhibit 35: Top three countries in Americas
  • Exhibit 36: Global systemic psoriasis therapeutics market in EMEA - Market size and forecast 2017-2022 ($ bn)
  • Exhibit 37: Global systemic psoriasis therapeutics market in EMEA - Year-over-year growth 2018-2022 (%)
  • Exhibit 38: Top three countries in EMEA
  • Exhibit 39: Global systemic psoriasis therapeutics market in APAC - Market size and forecast 2017-2022 ($ bn)
  • Exhibit 40: Global systemic psoriasis therapeutics market in APAC - Year-over-year growth 2018-2022 (%)
  • Exhibit 41: Top three countries in APAC
  • Exhibit 42: Market opportunity
  • Exhibit 43: Vendor landscape
  • Exhibit 44: Landscape disruption
  • Exhibit 45: Vendors covered
  • Exhibit 46: Vendor classification
  • Exhibit 47: Market positioning of vendors
  • Exhibit 48: AbbVie overview
  • Exhibit 49: AbbVie - Business segments
  • Exhibit 50: AbbVie - Organizational developments
  • Exhibit 51: AbbVie - Geographic focus
  • Exhibit 52: AbbVie - Segment focus
  • Exhibit 53: AbbVie - Key offerings
  • Exhibit 54: Amgen overview
  • Exhibit 55: Amgen - Business Segments
  • Exhibit 56: Amgen - Organizational developments
  • Exhibit 57: Amgen - Geographic focus
  • Exhibit 58: Amgen - Segment focus
  • Exhibit 59: Amgen - Key offerings
  • Exhibit 60: Celgene overview
  • Exhibit 61: Celgene - Business segments
  • Exhibit 62: Celgene - Organizational developments
  • Exhibit 63: Celgene - Geographic focus
  • Exhibit 64: Celgene - Segment focus
  • Exhibit 65: Celgene - Key offerings
  • Exhibit 66: Johnson & Johnson overview
  • Exhibit 67: Johnson & Johnson - Business segments
  • Exhibit 68: Johnson & Johnson - Organizational developments
  • Exhibit 69: Johnson & Johnson - Geographic focus
  • Exhibit 70: Johnson & Johnson - Segment focus
  • Exhibit 71: Johnson & Johnson - Key offerings
Back to Top